Stocks · News reference
This Humana Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Analysts change outlook on top names, including PAY, MAS, FVRR, HUM, and SITE. See their ratings and price targets on Benzinga's analyst ratings page.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Fiverr to Release Third Quarter 2026 Results on October 29, 2026
Fiverr International Ltd. announced it will release third quarter 2026 financial results on October 29, 2026, before market open, followed by a management conference call and webcast at 8:30 a.m. ET to discuss business and financial performance.
Generative Engine Optimization Emerges as the Holiday Season's Fastest-Growing Service
According to Fiverr's 2026 Holiday Marketing Index, retailers are combining AI tools with freelance talent to optimize search visibility and build consumer trust. While 67% of search specialists report rising demand for generative engine optimization, 69% of UGC freelancers report increased holiday demand as retailers recognize that authentic, human-created content resonates more with shoppers than AI-generated alternatives. The survey reveals a broader shift toward hiring specialists for strategy and advice rather than execution alone.
QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins
UnitedHealth expects Medicaid margins to bottom in 2026 and improve through 2028, UnitedHealthcare CEO Tim Noel says on earnings call.
Humana To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Analysts cut targets for Duke, Hyatt, Pershing Square, Carlisle, Upstart, Arch Capital and Meta; raised VF, Rexford and SentinelOne.
Mizuho Maintains Outperform on Humana, Raises Price Target to $495
Mizuho analyst Ann Hynes maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $468 to $495.